Sutton's Law

Kleiman and Hyde discuss the article The Nature of Prefrontal Cortical GABA Neuron Alterations in Schizophrenia: Markedly Lower Somatostatin and Parvalbumin Gene Expression Without Missing Neurons by Dienel et al. Using postmortem human brain to elucidate the molecular biology of brain disease is a...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of psychiatry 2023-07, Vol.180 (7), p.465-466
Main Authors: Kleinman, Joel E, Hyde, Thomas M
Format: Article
Language:English
Subjects:
Brain
Neurons
Parkinson's disease
Schizophrenia
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c329t-2d3df1dda367689431e2c20a4a12b14820041606f9df30550fe93fde9645da433
cites cdi_FETCH-LOGICAL-c329t-2d3df1dda367689431e2c20a4a12b14820041606f9df30550fe93fde9645da433
container_end_page 466
container_issue 7
container_start_page 465
container_title The American journal of psychiatry
container_volume 180
creator Kleinman, Joel E
Hyde, Thomas M
description Kleiman and Hyde discuss the article The Nature of Prefrontal Cortical GABA Neuron Alterations in Schizophrenia: Markedly Lower Somatostatin and Parvalbumin Gene Expression Without Missing Neurons by Dienel et al. Using postmortem human brain to elucidate the molecular biology of brain disease is a strategy consistent with Sutton's Law. The work of Ehringer and Hornykiewicz, which found decreased dopamine in the striatum of postmortem brains of patients with Parkinson's disease, was a resounding demonstration of the wisdom of this strategy. It paved the way for the use of L-dopa, the metabolic precursor of dopamine, in the treatment of Parkinson' disease .
doi_str_mv 10.1176/appi.ajp.20230403
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2832576207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2832576207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c329t-2d3df1dda367689431e2c20a4a12b14820041606f9df30550fe93fde9645da433</originalsourceid><addsrcrecordid>eNpdkEtLw0AUhQdRbG39AW5EcKGb1Dv3ziOzlOILCi5UcDdMMzOQ0jYxkyD-exPaunB1OfCdw-Vj7ILDjHOt7lxdlzO3qmcISCCAjtiYS5KZRsyP2RgAMDOSPkfsLKVVH4E0nrIRaTIIAsds-ta1bbW9SVcL9z1lJ9GtUzjf3wn7eHx4nz9ni9enl_n9IisITZuhJx-5946UVrkRxAMWCE44jksucgQQXIGKxkcCKSEGQ9EHo4T0ThBN2O1ut26qry6k1m7KVIT12m1D1SWLOaHUCkH36PU_dFV1zbb_bqAIhQYheorvqKKpUmpCtHVTblzzYznYQZUdVNlelT2o6juX--VuuQn-r3FwQ7-WaWHF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2833247044</pqid></control><display><type>article</type><title>Sutton's Law</title><source>American Psychiatric Publishing Journals (1997-Present)</source><creator>Kleinman, Joel E ; Hyde, Thomas M</creator><creatorcontrib>Kleinman, Joel E ; Hyde, Thomas M</creatorcontrib><description>Kleiman and Hyde discuss the article The Nature of Prefrontal Cortical GABA Neuron Alterations in Schizophrenia: Markedly Lower Somatostatin and Parvalbumin Gene Expression Without Missing Neurons by Dienel et al. Using postmortem human brain to elucidate the molecular biology of brain disease is a strategy consistent with Sutton's Law. The work of Ehringer and Hornykiewicz, which found decreased dopamine in the striatum of postmortem brains of patients with Parkinson's disease, was a resounding demonstration of the wisdom of this strategy. It paved the way for the use of L-dopa, the metabolic precursor of dopamine, in the treatment of Parkinson' disease .</description><identifier>ISSN: 0002-953X</identifier><identifier>EISSN: 1535-7228</identifier><identifier>DOI: 10.1176/appi.ajp.20230403</identifier><identifier>PMID: 37392042</identifier><language>eng</language><publisher>United States: American Psychiatric Association</publisher><subject>Brain ; Neurons ; Parkinson's disease ; Schizophrenia</subject><ispartof>The American journal of psychiatry, 2023-07, Vol.180 (7), p.465-466</ispartof><rights>Copyright American Psychiatric Association Jul 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c329t-2d3df1dda367689431e2c20a4a12b14820041606f9df30550fe93fde9645da433</citedby><cites>FETCH-LOGICAL-c329t-2d3df1dda367689431e2c20a4a12b14820041606f9df30550fe93fde9645da433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,2842,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37392042$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kleinman, Joel E</creatorcontrib><creatorcontrib>Hyde, Thomas M</creatorcontrib><title>Sutton's Law</title><title>The American journal of psychiatry</title><addtitle>Am J Psychiatry</addtitle><description>Kleiman and Hyde discuss the article The Nature of Prefrontal Cortical GABA Neuron Alterations in Schizophrenia: Markedly Lower Somatostatin and Parvalbumin Gene Expression Without Missing Neurons by Dienel et al. Using postmortem human brain to elucidate the molecular biology of brain disease is a strategy consistent with Sutton's Law. The work of Ehringer and Hornykiewicz, which found decreased dopamine in the striatum of postmortem brains of patients with Parkinson's disease, was a resounding demonstration of the wisdom of this strategy. It paved the way for the use of L-dopa, the metabolic precursor of dopamine, in the treatment of Parkinson' disease .</description><subject>Brain</subject><subject>Neurons</subject><subject>Parkinson's disease</subject><subject>Schizophrenia</subject><issn>0002-953X</issn><issn>1535-7228</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpdkEtLw0AUhQdRbG39AW5EcKGb1Dv3ziOzlOILCi5UcDdMMzOQ0jYxkyD-exPaunB1OfCdw-Vj7ILDjHOt7lxdlzO3qmcISCCAjtiYS5KZRsyP2RgAMDOSPkfsLKVVH4E0nrIRaTIIAsds-ta1bbW9SVcL9z1lJ9GtUzjf3wn7eHx4nz9ni9enl_n9IisITZuhJx-5946UVrkRxAMWCE44jksucgQQXIGKxkcCKSEGQ9EHo4T0ThBN2O1ut26qry6k1m7KVIT12m1D1SWLOaHUCkH36PU_dFV1zbb_bqAIhQYheorvqKKpUmpCtHVTblzzYznYQZUdVNlelT2o6juX--VuuQn-r3FwQ7-WaWHF</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Kleinman, Joel E</creator><creator>Hyde, Thomas M</creator><general>American Psychiatric Association</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20230701</creationdate><title>Sutton's Law</title><author>Kleinman, Joel E ; Hyde, Thomas M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c329t-2d3df1dda367689431e2c20a4a12b14820041606f9df30550fe93fde9645da433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Brain</topic><topic>Neurons</topic><topic>Parkinson's disease</topic><topic>Schizophrenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kleinman, Joel E</creatorcontrib><creatorcontrib>Hyde, Thomas M</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kleinman, Joel E</au><au>Hyde, Thomas M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sutton's Law</atitle><jtitle>The American journal of psychiatry</jtitle><addtitle>Am J Psychiatry</addtitle><date>2023-07-01</date><risdate>2023</risdate><volume>180</volume><issue>7</issue><spage>465</spage><epage>466</epage><pages>465-466</pages><issn>0002-953X</issn><eissn>1535-7228</eissn><abstract>Kleiman and Hyde discuss the article The Nature of Prefrontal Cortical GABA Neuron Alterations in Schizophrenia: Markedly Lower Somatostatin and Parvalbumin Gene Expression Without Missing Neurons by Dienel et al. Using postmortem human brain to elucidate the molecular biology of brain disease is a strategy consistent with Sutton's Law. The work of Ehringer and Hornykiewicz, which found decreased dopamine in the striatum of postmortem brains of patients with Parkinson's disease, was a resounding demonstration of the wisdom of this strategy. It paved the way for the use of L-dopa, the metabolic precursor of dopamine, in the treatment of Parkinson' disease .</abstract><cop>United States</cop><pub>American Psychiatric Association</pub><pmid>37392042</pmid><doi>10.1176/appi.ajp.20230403</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-953X
ispartof The American journal of psychiatry, 2023-07, Vol.180 (7), p.465-466
issn 0002-953X
1535-7228
language eng
recordid cdi_proquest_miscellaneous_2832576207
source American Psychiatric Publishing Journals (1997-Present)
subjects Brain
Neurons
Parkinson's disease
Schizophrenia
title Sutton's Law
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T09%3A04%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sutton's%20Law&rft.jtitle=The%20American%20journal%20of%20psychiatry&rft.au=Kleinman,%20Joel%20E&rft.date=2023-07-01&rft.volume=180&rft.issue=7&rft.spage=465&rft.epage=466&rft.pages=465-466&rft.issn=0002-953X&rft.eissn=1535-7228&rft_id=info:doi/10.1176/appi.ajp.20230403&rft_dat=%3Cproquest_cross%3E2832576207%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c329t-2d3df1dda367689431e2c20a4a12b14820041606f9df30550fe93fde9645da433%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2833247044&rft_id=info:pmid/37392042&rfr_iscdi=true